Considering that IFN may contribute to the tissue degradative effects of TNF-α already induced by SARS-CoV infection, the problem is to polarize the mouse immune system to a Th2 inflammatory response, with undesired consequences to patient recovery from SARS-CoV infection when treated with an IFN. Here, IFNA1 is linked to severe acute respiratory syndrome.